Detailed TOC of Global Live Attenuated Influenza Vaccine (LAIV) Market Research Report 2025
1 Live Attenuated Influenza Vaccine (LAIV) Market Overview
1.1 Product Definition
1.2 Live Attenuated Influenza Vaccine (LAIV) by Type
1.2.1 Global Live Attenuated Influenza Vaccine (LAIV) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Trivalent Flu Vaccine
1.2.3 Quadrivalent Flu Vaccine
1.3 Live Attenuated Influenza Vaccine (LAIV) by Application
1.3.1 Global Live Attenuated Influenza Vaccine (LAIV) Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Public Health Agency
1.3.5 Other
1.4 Global Live Attenuated Influenza Vaccine (LAIV) Market Size Estimates and Forecasts
1.4.1 Global Live Attenuated Influenza Vaccine (LAIV) Revenue 2020-2031
1.4.2 Global Live Attenuated Influenza Vaccine (LAIV) Sales 2020-2031
1.4.3 Global Live Attenuated Influenza Vaccine (LAIV) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Live Attenuated Influenza Vaccine (LAIV) Market Competition by Manufacturers
2.1 Global Live Attenuated Influenza Vaccine (LAIV) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Live Attenuated Influenza Vaccine (LAIV) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Live Attenuated Influenza Vaccine (LAIV) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Live Attenuated Influenza Vaccine (LAIV), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Live Attenuated Influenza Vaccine (LAIV), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Live Attenuated Influenza Vaccine (LAIV), Product Type & Application
2.7 Global Key Manufacturers of Live Attenuated Influenza Vaccine (LAIV), Date of Enter into This Industry
2.8 Global Live Attenuated Influenza Vaccine (LAIV) Market Competitive Situation and Trends
2.8.1 Global Live Attenuated Influenza Vaccine (LAIV) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Live Attenuated Influenza Vaccine (LAIV) Players Market Share by Revenue
2.8.3 Global Live Attenuated Influenza Vaccine (LAIV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Live Attenuated Influenza Vaccine (LAIV) Market Scenario by Region
3.1 Global Live Attenuated Influenza Vaccine (LAIV) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Region: 2020-2031
3.2.1 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Region: 2020-2025
3.2.2 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Region: 2026-2031
3.3 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Region: 2020-2031
3.3.1 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Region: 2020-2025
3.3.2 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Region: 2026-2031
3.4 North America Live Attenuated Influenza Vaccine (LAIV) Market Facts & Figures by Country
3.4.1 North America Live Attenuated Influenza Vaccine (LAIV) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Live Attenuated Influenza Vaccine (LAIV) Sales by Country (2020-2031)
3.4.3 North America Live Attenuated Influenza Vaccine (LAIV) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Live Attenuated Influenza Vaccine (LAIV) Market Facts & Figures by Country
3.5.1 Europe Live Attenuated Influenza Vaccine (LAIV) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Live Attenuated Influenza Vaccine (LAIV) Sales by Country (2020-2031)
3.5.3 Europe Live Attenuated Influenza Vaccine (LAIV) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Live Attenuated Influenza Vaccine (LAIV) Market Facts & Figures by Region
3.6.1 Asia Pacific Live Attenuated Influenza Vaccine (LAIV) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Live Attenuated Influenza Vaccine (LAIV) Sales by Region (2020-2031)
3.6.3 Asia Pacific Live Attenuated Influenza Vaccine (LAIV) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Live Attenuated Influenza Vaccine (LAIV) Market Facts & Figures by Country
3.7.1 Latin America Live Attenuated Influenza Vaccine (LAIV) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Live Attenuated Influenza Vaccine (LAIV) Sales by Country (2020-2031)
3.7.3 Latin America Live Attenuated Influenza Vaccine (LAIV) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Live Attenuated Influenza Vaccine (LAIV) Market Facts & Figures by Country
3.8.1 Middle East and Africa Live Attenuated Influenza Vaccine (LAIV) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Live Attenuated Influenza Vaccine (LAIV) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Live Attenuated Influenza Vaccine (LAIV) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Type (2020-2031)
4.1.1 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Type (2020-2025)
4.1.2 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Type (2026-2031)
4.1.3 Global Live Attenuated Influenza Vaccine (LAIV) Sales Market Share by Type (2020-2031)
4.2 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Type (2020-2031)
4.2.1 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Type (2020-2025)
4.2.2 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Type (2026-2031)
4.2.3 Global Live Attenuated Influenza Vaccine (LAIV) Revenue Market Share by Type (2020-2031)
4.3 Global Live Attenuated Influenza Vaccine (LAIV) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Application (2020-2031)
5.1.1 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Application (2020-2025)
5.1.2 Global Live Attenuated Influenza Vaccine (LAIV) Sales by Application (2026-2031)
5.1.3 Global Live Attenuated Influenza Vaccine (LAIV) Sales Market Share by Application (2020-2031)
5.2 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Application (2020-2031)
5.2.1 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Application (2020-2025)
5.2.2 Global Live Attenuated Influenza Vaccine (LAIV) Revenue by Application (2026-2031)
5.2.3 Global Live Attenuated Influenza Vaccine (LAIV) Revenue Market Share by Application (2020-2031)
5.3 Global Live Attenuated Influenza Vaccine (LAIV) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Pasteur Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AstraZeneca Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 CSL
6.3.1 CSL Company Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CSL Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Company Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbott Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Serum Institute
6.6.1 Serum Institute Company Information
6.6.2 Serum Institute Description and Business Overview
6.6.3 Serum Institute Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Serum Institute Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.6.5 Serum Institute Recent Developments/Updates
6.7 Fluenz Tetra
6.7.1 Fluenz Tetra Company Information
6.7.2 Fluenz Tetra Description and Business Overview
6.7.3 Fluenz Tetra Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fluenz Tetra Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.7.5 Fluenz Tetra Recent Developments/Updates
6.8 Cytiva
6.8.1 Cytiva Company Information
6.8.2 Cytiva Description and Business Overview
6.8.3 Cytiva Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cytiva Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.8.5 Cytiva Recent Developments/Updates
6.9 BioDiem
6.9.1 BioDiem Company Information
6.9.2 BioDiem Description and Business Overview
6.9.3 BioDiem Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.9.4 BioDiem Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.9.5 BioDiem Recent Developments/Updates
6.10 FluMist
6.10.1 FluMist Company Information
6.10.2 FluMist Description and Business Overview
6.10.3 FluMist Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.10.4 FluMist Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.10.5 FluMist Recent Developments/Updates
6.11 GSK
6.11.1 GSK Company Information
6.11.2 GSK Description and Business Overview
6.11.3 GSK Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GSK Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.11.5 GSK Recent Developments/Updates
6.12 ChangChun High & New Technology
6.12.1 ChangChun High & New Technology Company Information
6.12.2 ChangChun High & New Technology Description and Business Overview
6.12.3 ChangChun High & New Technology Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ChangChun High & New Technology Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.12.5 ChangChun High & New Technology Recent Developments/Updates
6.13 BCHT Biotechnology
6.13.1 BCHT Biotechnology Company Information
6.13.2 BCHT Biotechnology Description and Business Overview
6.13.3 BCHT Biotechnology Live Attenuated Influenza Vaccine (LAIV) Sales, Revenue and Gross Margin (2020-2025)
6.13.4 BCHT Biotechnology Live Attenuated Influenza Vaccine (LAIV) Product Portfolio
6.13.5 BCHT Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Live Attenuated Influenza Vaccine (LAIV) Industry Chain Analysis
7.2 Live Attenuated Influenza Vaccine (LAIV) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Live Attenuated Influenza Vaccine (LAIV) Production Mode & Process Analysis
7.4 Live Attenuated Influenza Vaccine (LAIV) Sales and Marketing
7.4.1 Live Attenuated Influenza Vaccine (LAIV) Sales Channels
7.4.2 Live Attenuated Influenza Vaccine (LAIV) Distributors
7.5 Live Attenuated Influenza Vaccine (LAIV) Customer Analysis
8 Live Attenuated Influenza Vaccine (LAIV) Market Dynamics
8.1 Live Attenuated Influenza Vaccine (LAIV) Industry Trends
8.2 Live Attenuated Influenza Vaccine (LAIV) Market Drivers
8.3 Live Attenuated Influenza Vaccine (LAIV) Market Challenges
8.4 Live Attenuated Influenza Vaccine (LAIV) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Download FREE Sample Report
